| IMUGENE LTD. |
| Australien |
| Gesundheit |
| AU000000IMU9 / 891460 |
| ILA (Frankfurt) |
| FRA:ILA, ETR:ILA, ILA:GR |
| - |
| https://www.imugene.com/ |
|
Imugene Ltd. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer treatment. The company specializes in activating the immune system to target and eradicate tumours, leveraging a diverse pipeline o..
>Volltext.. |
| 34.31 Mio. EUR |
| 29.03 Mio. EUR |
| - |
| - |
| -33.82 Mio. EUR |
| -0.13 EUR |
| 2.89 Mio. EUR |
| 8.17 Mio. EUR |
| -36.46 Mio. EUR |
| 0.77 |
| - |
| 51.2% |
| - |
| - |
| - |
| - |
| IMUGENE |
| 04.04.26 |
|